Cyclica
Cyclica - From Molecule to Medicine
Cyclica is the partner of choice for data-driven drug discovery.
We advance molecules that embrace the complexity of the disease. Cyclica is the partner of choice for data-driven drug discovery. Our computational approach to polypharmacology is unique in the industry. We use a proteome-wide lens to evaluate multiple novel and rare on and off-target interactions simultaneously. We’re also the only company of our kind that integrates science to advance molecules
09/13/2022
After a little summer pause, M2M is back!
As part of our AI in drug discovery campaign, we have an exciting roundtable lined up titled: “AI in Drug Discovery: Successes, Opportunities and Pitfalls.”
And, what would a panel be without the brightest and the best industry leaders? Ali Madani, Andreas Bender, Brandon Allgood, Pat Walters, and Naheed Kurji.
Registration opens up today! https://lnkd.in/gAPrhzzU
cc: Valo The Alliance for Artificial Intelligence in Healthcare (AAIH) Relay Therapeutics Cambridge University Press – Academic
09/08/2022
In the "bonus" M2M episode, our director of machine learning, Dr. Ali Madani & our machine learning researcher, Dr. Nasim Abdollahi introduce a machine learning framework, using DeepMind's AlphaFold2 structure-augmented protein representations, an essential component in the early AI Drug Discovery process.
Watch the episode here -> https://lnkd.in/gUC2AqKj
08/30/2022
At Cyclica, we’re constantly pushing the boundaries of discovery to address the complexity of the disease.
In collaboration with The Structural Genomics Consortium (SGC), we explored the low data target, DCAF-1, resulting in the first disclosed co-crystallized structure. DCAF-1 is a key component in proteasomal degradation, with a novel ligand to support targeted therapeutics discovery.
Press release 👉 https://lnkd.in/gi3cPrSU
08/25/2022
As part of our AI in drug discovery campaign, Dr. Ali Madani explains the application of AI in drug discovery in his new blog post.
⦿ Check out the post 👉 shorturl.at/efqX7.
⦿ To learn more about our drug discovery application, visit 👉 shorturl.at/bgwY7.
08/18/2022
The current uncertainties globally undeniably impact public and private markets and investments.
This directly impacts how entrepreneurs and operators manage companies. In this post, our CEO, Naheed Kurji, shares his thoughts & some lessons.
📖 👉 👉 https://bit.ly/3K4KNtc (Link in stories)
08/09/2022
The next podcast (5th) episode of Cyclica's M2M (molecule to medicine) is now available on Spotify.
In this episode, Dr. Mike Palovich (Chief Science Officer at Cyclica) & Naheed Kurji (President, Co-founder & CEO of Cyclica) discuss about the journey of a molecule to medicine.
🎧 https://spoti.fi/3vURoR1
08/05/2022
Fresh off the blog!
Our Chief Platform Officer, Dr Stephen MacKinnon, explores new research possibilities following the release of 200 million AlphaFold2 protein structures.
Read the post ➡️ https://bit.ly/3bsR2dD.
08/03/2022
We're looking forward to working with our newest partner, Samjin Pharm, where we will collectively work on proposed novel targets to develop drug target candidates.
Read the press release here 👉 https://bit.ly/3BzE1cJ
07/28/2022
Cyclica was named one of Business Insider’s Top Biotech Startups set to take off in the next 12 months.
We’re incredibly humbled and proud of our team after just learning that Business Insider Insider has named Cyclica to their top list of biotech start-up companies set to take off in the next 12 months.
The prestigious nomination came from Chris Garabedian, who indicates that: “Cyclica could end up being best-in-class in this space, even though others have gotten a lot more attention and attracted a lot more capital.”
Thanks, Chris and to all who have supported Cyclica throughout our journey as we continue to embrace the complexity of the disease.
07/11/2022
Breaking news
We (Cyclica) are hiring, and we are looking to fill 4 positions:
Drug discovery scientist,
computational scientist,
software developer &
computational scientist.
Why join Cyclica?
- awesome team
- fast paced environment
- great culture
- awesome perks, including a two-week company-wide shutdown (summer & winter), unlimited wellness days, four weeks of paid vacation & much more.
Apply here - https://lnkd.in/gUU4jkZ5
07/08/2022
The 3rd episode of our M2M podcast is now available on Spotify!
In this episode, women in STEM trailblazers, Dr. Marti Head & Dr. Melissa Landon discuss small molecules in drug discovery - from the perspective of two brilliant computational scientist.
🎧 here - https://lnkd.in/gzee-yUt
07/07/2022
Check out our newest blog post, where Naheed Kurji shares his take on 5 of Walter Isaacson's books:
📖The Innovators
📖Steve Jobs
📖Leonardo Da Vinci
📖Code Breakers (Jennifer Doudna)
📖Einstein
Read the blog 👉 https://lnkd.in/g3APpbdx
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
207 Queens Quay West #420
Toronto, ON
M5J1A7